5'-n-methylcarboxamideadenosine and Lung Neoplasms

5'-n-methylcarboxamideadenosine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Patel, A; Patel, L; Patel, M; Patel, S; Shah, S; Shah, U; Solanki, N	1

Other Studies

1 other study(ies) available for 5'-n-methylcarboxamideadenosine and Lung Neoplasms

Article	Year
Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α. Current drug discovery technologies, 2022, Volume: 19, Issue:1 Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Disease Models, Animal; Doxorubicin; Heterografts; Humans; Lung Neoplasms; Mice; Molecular Docking Simulation; Rats; Tumor Necrosis Factor-alpha	2022

Article

Year

Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α.

Current drug discovery technologies, 2022, Volume: 19, Issue:1

Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Disease Models, Animal; Doxorubicin; Heterografts; Humans; Lung Neoplasms; Mice; Molecular Docking Simulation; Rats; Tumor Necrosis Factor-alpha

2022